|
KENILWORTH, N.J. (AP) -- Pharmaceuticals maker Schering-Plough Corp. said Wednesday it priced a public offering of $2 billion in senior notes. The company is selling $1 billion of 6 percent senior notes due 2017 and $1 billion of 6.55 percent senior notes due 2037. According to a regulatory filing, the company plans to use proceeds to help fund the purchase of Organon BioSciences. Schering-Plough announced the $14.4 billion acquisition in March. Goldman, Sachs & Co. is coordinating the offering, and BNP Paribas Securities Corp., Credit Suisse Securities (USA) LLC and J.P. Morgan Securities Inc. are the joint bookrunners. The offering is expected to close Sept. 17, subject to customary closing conditions. In after-hours trading, shares of Schering-Plough added 18 cents to $30.56.
|